Browsed by
Category: Energy and Commerce Committee

21st Century Cures Act introduced ?>

21st Century Cures Act introduced

Throughout most of 2014, the U.S. House Energy and Commerce committee was engaged in the 21st Century Cures initiative. The goal of this initiative was to speed the discovery, development and delivery of therapies for the myriad illnesses that affect Americans today.

What we’re watching in 2015: 21st Century Cures ?>

What we’re watching in 2015: 21st Century Cures

In this four-part series, we will take a look at important issues for the research community in 2015. Today’s topic is the 21st Century Cures initiative. In the spring of 2014, Reps. Diana DeGette, D-Colorado, and Fred Upton, R-Michigan, made an important announcement concerning scientists.

Support from the House for a “Path to 21st Century Cures” ?>

Support from the House for a “Path to 21st Century Cures”

Last week the U.S. Senate Appropriations committee highlighted the need to drive innovation through federal investments. This week, the U.S. House Energy and Commerce committee led by Rep. Fred Upton, R-Michigan, and Rep. Diana DeGette, D-Colorado, launched a new initiative called “A Path to 21st Century Cures.” This new initiative brought together leaders from the government, non-profit sector and private industry, including Francis Collins, director of the National Institutes of Health, Janet Woodcock, director of the Food and Drug Administration’s…

Read More Read More

Scrutiny on spending at the National Institutes of Health increasing ?>

Scrutiny on spending at the National Institutes of Health increasing

Science advocacy groups, such as the ASBMB, urge Congress to increase the budgets of the National Institutes of Health and other research-funding agencies to continue our national investment in groundbreaking research that will improve the public health and energize our economy. However, some members of Congress have begun to turn the tables suggesting that research funding agencies could fund more research if they were smarter with how they invested their money. The debate, though, is what qualifies as a smart…

Read More Read More

House panel considers risks, rewards of synthetic genomics ?>

House panel considers risks, rewards of synthetic genomics

On May 27, in response to the recent announcement that scientists had created the first microbe with a man-made genome, the U.S. House Energy and Commerce Committee heard expert testimony on the scientific and ethical implications of synthetic biology. During the hearing, representatives sought to understand the emerging technology’s benefits and risks.